Loading…

Long-term survival after colonic stenting and restenting for malignant colonic obstruction

The mortality risk for emergency surgery for colonic obstruction ranges from 9 to 27 per cent.1 For patients with unresectable tumors, stoma creation is still considered the standard treatment of large bowel obstruction, but this procedure is also associated with significant morbidity of approximate...

Full description

Saved in:
Bibliographic Details
Published in:The American surgeon 2010-04, Vol.76 (4), p.457-459
Main Authors: Noto, Khristian A, Almario, Christopher, Maxwell, Pinckney J, Mitchell, Edith P, Isenberg, Gerald A, Goldstein, Scott D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c292t-2dfaaefd1557aefed2f4b7484220ddf806c160962b4d015e8e0c909f19e9060f3
container_end_page 459
container_issue 4
container_start_page 457
container_title The American surgeon
container_volume 76
creator Noto, Khristian A
Almario, Christopher
Maxwell, Pinckney J
Mitchell, Edith P
Isenberg, Gerald A
Goldstein, Scott D
description The mortality risk for emergency surgery for colonic obstruction ranges from 9 to 27 per cent.1 For patients with unresectable tumors, stoma creation is still considered the standard treatment of large bowel obstruction, but this procedure is also associated with significant morbidity of approximately 19 per cent and mortality approaching 10 per cent.2 Since its introduction in 1992, self-expanding metallic stents (SEMS) have found increased use in recent years in the palliative relief of malignant colorectal obstructions.3 We present the case of a patient who underwent SEMS placement for a recurrent obstructing left colon cancer and subsequently presented 22 months after the procedure with reobstruction secondary to tumor ingrowth. The use of SEMS for relieving malignant colorectal obstructions either as a bridge to elective resection or for definitive palliative treatment has increased in recent years, achieving technical and clinical success rates exceeding 90 per cent.3 Patency of the stent and colon can be compromised by stent migration, collapse, or reobstruction.
doi_str_mv 10.1177/000313481007600434
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_212833775</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2021674681</sourcerecordid><originalsourceid>FETCH-LOGICAL-c292t-2dfaaefd1557aefed2f4b7484220ddf806c160962b4d015e8e0c909f19e9060f3</originalsourceid><addsrcrecordid>eNplkEtLAzEUhYMotlb_gAsJ7kdvHjOZLEV8QcGNbtwMmTzKlJmkJjMF_70prd24uhz4zrmHg9A1gTtChLgHAEYYrwmAqAA44ydoTsqyLGRN2Sma74BiR8zQRUrrLHlVknM0o8Ap0ErM0dcy-FUx2jjgNMVtt1U9Vi5rrEMffKdxGq0fO7_Cyhsc7VG6EPGg-m7llR-PdGjTGCc9dsFfojOn-mSvDneBPp-fPh5fi-X7y9vjw7LQVNKxoMYpZZ3JxUW-1lDHW8FrTikY42qoNKlAVrTlBkhpawtagnREWgkVOLZAt_vcTQzfUy7YrMMUfX7ZUEJrxoQoM0T3kI4hpWhds4ndoOJPQ6DZrdn8XzObbg7JUztYc7T8zcd-ARN6cF0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212833775</pqid></control><display><type>article</type><title>Long-term survival after colonic stenting and restenting for malignant colonic obstruction</title><source>SAGE</source><creator>Noto, Khristian A ; Almario, Christopher ; Maxwell, Pinckney J ; Mitchell, Edith P ; Isenberg, Gerald A ; Goldstein, Scott D</creator><creatorcontrib>Noto, Khristian A ; Almario, Christopher ; Maxwell, Pinckney J ; Mitchell, Edith P ; Isenberg, Gerald A ; Goldstein, Scott D</creatorcontrib><description>The mortality risk for emergency surgery for colonic obstruction ranges from 9 to 27 per cent.1 For patients with unresectable tumors, stoma creation is still considered the standard treatment of large bowel obstruction, but this procedure is also associated with significant morbidity of approximately 19 per cent and mortality approaching 10 per cent.2 Since its introduction in 1992, self-expanding metallic stents (SEMS) have found increased use in recent years in the palliative relief of malignant colorectal obstructions.3 We present the case of a patient who underwent SEMS placement for a recurrent obstructing left colon cancer and subsequently presented 22 months after the procedure with reobstruction secondary to tumor ingrowth. The use of SEMS for relieving malignant colorectal obstructions either as a bridge to elective resection or for definitive palliative treatment has increased in recent years, achieving technical and clinical success rates exceeding 90 per cent.3 Patency of the stent and colon can be compromised by stent migration, collapse, or reobstruction.</description><identifier>ISSN: 0003-1348</identifier><identifier>EISSN: 1555-9823</identifier><identifier>DOI: 10.1177/000313481007600434</identifier><identifier>PMID: 20420267</identifier><language>eng</language><publisher>United States: SAGE PUBLICATIONS, INC</publisher><subject>Aged ; Chemotherapy ; Colonic Neoplasms - diagnosis ; Colonic Neoplasms - therapy ; Humans ; Intestinal Obstruction - diagnosis ; Intestinal Obstruction - therapy ; Long term ; Male ; Medical treatment ; Mortality ; Neoplasm Recurrence, Local ; Palliative Care ; Retreatment ; Stents</subject><ispartof>The American surgeon, 2010-04, Vol.76 (4), p.457-459</ispartof><rights>Copyright Southeastern Surgical Congress Apr 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c292t-2dfaaefd1557aefed2f4b7484220ddf806c160962b4d015e8e0c909f19e9060f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20420267$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Noto, Khristian A</creatorcontrib><creatorcontrib>Almario, Christopher</creatorcontrib><creatorcontrib>Maxwell, Pinckney J</creatorcontrib><creatorcontrib>Mitchell, Edith P</creatorcontrib><creatorcontrib>Isenberg, Gerald A</creatorcontrib><creatorcontrib>Goldstein, Scott D</creatorcontrib><title>Long-term survival after colonic stenting and restenting for malignant colonic obstruction</title><title>The American surgeon</title><addtitle>Am Surg</addtitle><description>The mortality risk for emergency surgery for colonic obstruction ranges from 9 to 27 per cent.1 For patients with unresectable tumors, stoma creation is still considered the standard treatment of large bowel obstruction, but this procedure is also associated with significant morbidity of approximately 19 per cent and mortality approaching 10 per cent.2 Since its introduction in 1992, self-expanding metallic stents (SEMS) have found increased use in recent years in the palliative relief of malignant colorectal obstructions.3 We present the case of a patient who underwent SEMS placement for a recurrent obstructing left colon cancer and subsequently presented 22 months after the procedure with reobstruction secondary to tumor ingrowth. The use of SEMS for relieving malignant colorectal obstructions either as a bridge to elective resection or for definitive palliative treatment has increased in recent years, achieving technical and clinical success rates exceeding 90 per cent.3 Patency of the stent and colon can be compromised by stent migration, collapse, or reobstruction.</description><subject>Aged</subject><subject>Chemotherapy</subject><subject>Colonic Neoplasms - diagnosis</subject><subject>Colonic Neoplasms - therapy</subject><subject>Humans</subject><subject>Intestinal Obstruction - diagnosis</subject><subject>Intestinal Obstruction - therapy</subject><subject>Long term</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Mortality</subject><subject>Neoplasm Recurrence, Local</subject><subject>Palliative Care</subject><subject>Retreatment</subject><subject>Stents</subject><issn>0003-1348</issn><issn>1555-9823</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNplkEtLAzEUhYMotlb_gAsJ7kdvHjOZLEV8QcGNbtwMmTzKlJmkJjMF_70prd24uhz4zrmHg9A1gTtChLgHAEYYrwmAqAA44ydoTsqyLGRN2Sma74BiR8zQRUrrLHlVknM0o8Ap0ErM0dcy-FUx2jjgNMVtt1U9Vi5rrEMffKdxGq0fO7_Cyhsc7VG6EPGg-m7llR-PdGjTGCc9dsFfojOn-mSvDneBPp-fPh5fi-X7y9vjw7LQVNKxoMYpZZ3JxUW-1lDHW8FrTikY42qoNKlAVrTlBkhpawtagnREWgkVOLZAt_vcTQzfUy7YrMMUfX7ZUEJrxoQoM0T3kI4hpWhds4ndoOJPQ6DZrdn8XzObbg7JUztYc7T8zcd-ARN6cF0</recordid><startdate>201004</startdate><enddate>201004</enddate><creator>Noto, Khristian A</creator><creator>Almario, Christopher</creator><creator>Maxwell, Pinckney J</creator><creator>Mitchell, Edith P</creator><creator>Isenberg, Gerald A</creator><creator>Goldstein, Scott D</creator><general>SAGE PUBLICATIONS, INC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7QL</scope><scope>7RV</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>201004</creationdate><title>Long-term survival after colonic stenting and restenting for malignant colonic obstruction</title><author>Noto, Khristian A ; Almario, Christopher ; Maxwell, Pinckney J ; Mitchell, Edith P ; Isenberg, Gerald A ; Goldstein, Scott D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c292t-2dfaaefd1557aefed2f4b7484220ddf806c160962b4d015e8e0c909f19e9060f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Aged</topic><topic>Chemotherapy</topic><topic>Colonic Neoplasms - diagnosis</topic><topic>Colonic Neoplasms - therapy</topic><topic>Humans</topic><topic>Intestinal Obstruction - diagnosis</topic><topic>Intestinal Obstruction - therapy</topic><topic>Long term</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Mortality</topic><topic>Neoplasm Recurrence, Local</topic><topic>Palliative Care</topic><topic>Retreatment</topic><topic>Stents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Noto, Khristian A</creatorcontrib><creatorcontrib>Almario, Christopher</creatorcontrib><creatorcontrib>Maxwell, Pinckney J</creatorcontrib><creatorcontrib>Mitchell, Edith P</creatorcontrib><creatorcontrib>Isenberg, Gerald A</creatorcontrib><creatorcontrib>Goldstein, Scott D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database (ProQuest)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Family Health Database (Proquest)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>The American surgeon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Noto, Khristian A</au><au>Almario, Christopher</au><au>Maxwell, Pinckney J</au><au>Mitchell, Edith P</au><au>Isenberg, Gerald A</au><au>Goldstein, Scott D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term survival after colonic stenting and restenting for malignant colonic obstruction</atitle><jtitle>The American surgeon</jtitle><addtitle>Am Surg</addtitle><date>2010-04</date><risdate>2010</risdate><volume>76</volume><issue>4</issue><spage>457</spage><epage>459</epage><pages>457-459</pages><issn>0003-1348</issn><eissn>1555-9823</eissn><abstract>The mortality risk for emergency surgery for colonic obstruction ranges from 9 to 27 per cent.1 For patients with unresectable tumors, stoma creation is still considered the standard treatment of large bowel obstruction, but this procedure is also associated with significant morbidity of approximately 19 per cent and mortality approaching 10 per cent.2 Since its introduction in 1992, self-expanding metallic stents (SEMS) have found increased use in recent years in the palliative relief of malignant colorectal obstructions.3 We present the case of a patient who underwent SEMS placement for a recurrent obstructing left colon cancer and subsequently presented 22 months after the procedure with reobstruction secondary to tumor ingrowth. The use of SEMS for relieving malignant colorectal obstructions either as a bridge to elective resection or for definitive palliative treatment has increased in recent years, achieving technical and clinical success rates exceeding 90 per cent.3 Patency of the stent and colon can be compromised by stent migration, collapse, or reobstruction.</abstract><cop>United States</cop><pub>SAGE PUBLICATIONS, INC</pub><pmid>20420267</pmid><doi>10.1177/000313481007600434</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-1348
ispartof The American surgeon, 2010-04, Vol.76 (4), p.457-459
issn 0003-1348
1555-9823
language eng
recordid cdi_proquest_journals_212833775
source SAGE
subjects Aged
Chemotherapy
Colonic Neoplasms - diagnosis
Colonic Neoplasms - therapy
Humans
Intestinal Obstruction - diagnosis
Intestinal Obstruction - therapy
Long term
Male
Medical treatment
Mortality
Neoplasm Recurrence, Local
Palliative Care
Retreatment
Stents
title Long-term survival after colonic stenting and restenting for malignant colonic obstruction
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T09%3A34%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20survival%20after%20colonic%20stenting%20and%20restenting%20for%20malignant%20colonic%20obstruction&rft.jtitle=The%20American%20surgeon&rft.au=Noto,%20Khristian%20A&rft.date=2010-04&rft.volume=76&rft.issue=4&rft.spage=457&rft.epage=459&rft.pages=457-459&rft.issn=0003-1348&rft.eissn=1555-9823&rft_id=info:doi/10.1177/000313481007600434&rft_dat=%3Cproquest_cross%3E2021674681%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c292t-2dfaaefd1557aefed2f4b7484220ddf806c160962b4d015e8e0c909f19e9060f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=212833775&rft_id=info:pmid/20420267&rfr_iscdi=true